Skip to content

Clinical trials

Phase 3 COVID-19 trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 3 Country / region: Philippines Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20203
20218
20226
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status3
Recruiting2
Terminated2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clover Biopharmaceuticals AUS Pty2
Merck Sharp & Dohme LLC2
University of the Philippines2
Arcturus Therapeutics, Inc.1
AstraZeneca1
Atea Pharmaceuticals, Inc.1
Cellid Co., Ltd.1
EuBiologics Co.,Ltd1
Livzon Pharmaceutical Group Inc.1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1921
Coronavirus Infections2
Severe Acute Respiratory Syndrome2
Infections1
Influenza, Human1
Lung Diseases1
Respiratory Distress Syndrome1
Respiratory Tract Infections1
Virus Diseases1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.